Schipper Laurus F, van Hensbergen Yvette, Fibbe Willem E, Brand Anneke
Sanquin Blood Bank, Southwest Region, Leidenm, The Netherlands.
Transfusion. 2007 Dec;47(12):2305-14. doi: 10.1111/j.1537-2995.2007.01472.x. Epub 2007 Aug 30.
The NOD/SCID mouse is a widely used model for human cord blood (CB) transplantation. Engraftment is generally estimated with semiquantitative methods, measuring the percentage of human cells among mouse cells. To compare protocols aiming to improve hematopoietic recovery, quantitative methods to enumerate human cells would be preferred. This study describes a single-platform protocol to count human platelets (hPLTs) after transfusion and CB transplantation in the peripheral blood (PB) of the mouse.
With an anti-human CD41 antibody against hPLTs and counting beads, the sensitivity to detect hPLTs in mouse blood by flow cytometry was validated. PLT recovery after hPLT transfusions and PLT kinetics after transplantation with CB CD34+ cells was followed in time in NOD/SCID mice.
hPLTs could be reliably detected to a level as low as 1 PLT per microL with this single-platform protocol, what appeared to be at least 10 times more sensitive than detection with the dual-platform protocol. To verify the applicability for mouse studies, hPLTs were measured serially in transfusion and transplantation studies in NOD/SCID mice. The results showed that earlier detection of PLT recovery was feasible with the single-platform protocol.
A single-platform flow cytometry method can repeatedly measure low numbers of circulating hPLTs in the PB of the same mouse. This method may be helpful in search of new protocols aiming at accelerating PLT recovery after CB transplantation, but also in a number of clinical settings, such as monitoring PLT reconstitution after hematopoietic stem cell transplantation.
NOD/SCID小鼠是一种广泛应用于人类脐血(CB)移植的模型。通常采用半定量方法评估植入情况,即测量小鼠细胞中人类细胞的百分比。为了比较旨在改善造血恢复的方案,采用定量方法来计数人类细胞会更可取。本研究描述了一种单平台方案,用于在小鼠外周血(PB)中输注和CB移植后计数人类血小板(hPLTs)。
使用抗人类CD41抗体针对hPLTs和计数微球,通过流式细胞术检测小鼠血液中hPLTs的敏感性得到验证。在NOD/SCID小鼠中及时跟踪hPLT输注后的血小板恢复情况以及CB CD34+细胞移植后的血小板动力学。
使用这种单平台方案能够可靠地检测到低至每微升1个血小板水平的hPLTs,这似乎比双平台方案检测的灵敏度至少高10倍。为验证其在小鼠研究中的适用性,在NOD/SCID小鼠的输血和移植研究中连续测量hPLTs。结果表明,采用单平台方案更早检测血小板恢复是可行的。
单平台流式细胞术方法可以重复测量同一只小鼠外周血中数量较少的循环hPLTs。该方法可能有助于寻找旨在加速CB移植后血小板恢复的新方案,也有助于许多临床情况,如监测造血干细胞移植后的血小板重建。